That is darn good question. If I remember right, in the spring I kept reading that they were shooting for the fall to have FDA approval (or at least submitted for it). That has come and gone with little info on an expected approval. The only PR that seems to be comeing out is that they are speaking at different conferences/conventions and getting some print material out in some publications. Anyone else have any info on what what state the approval process is in for BiovaxID?
News 
Market Data 
Discover 
AI
